Gilead Sciences

Open: 82.0 Close: 81.59 Change: -0.41

Our AI found 5 flaws in Gilead Sciences Stock.

This document will help you to evaluate Gilead Sciences without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Gilead, Sciences, Change, stock, USD, Current, liver, …

Concept Map

Semantic Network

Stock Summary

Gilead Sciences, Inc. discovers, develops, and commercializes medicines in the areas of unmet medical need. The company provides Biktarvy, Genvoya, Descovy, Descogna, Odefsey,.

Today's Summary

Gilead Sciences stock quote is 81.59 USD today. Current trend is considered strongly bullish and GILD is experiencing selling pressure, which indicates risk of future bearish movement. Walletinvestor.com predicts future values.

Today's News

Gilead Sciences has sought to address some of the biggest challenges in liver disease for more than 20 years. “We look forward to sharing our latest findings in the treatment of people living with HDV with the broader liver community. The highest paying salary package reported for a Financial Analyst at Gilead Sciences sits at a yearly total compensation of $233,971. The median yearly total pay for the Financial Analyst role is $163,980. The PARP1 inhibitor, HRS-1167, is in development at Chinas Jiangsu. Gilead Sciences Contributes Additional $85 million to Its Foundation to Advance Health Equity. Gileads to Present Late Breaking Data and Real World Evidence Highlighting Key Hepatitis Indications at The Liver Meeting® 2023. HealthVerity partners with gilead sciences to support Women in Data Science. Gilead Sciences stock quote is 81.59 USD today. Current share price is $81.59. Current trend is considered strongly bullish and GILD is experiencing selling pressure, which indicates risk of future bearish movement. Gilead Sciences stock forecast: down to 81.456 USD. Walletinvestor.com predicts future values with technical analysis for wide selection of stocks like Gileadsciences. Current price today: ▼ 81.550 USD (-0.628%) Gilead Sciences, Inc. Stock Price Forecast for 2024 September 2024 Open: 78.523 Close: 79.636 Min: 81.523 Max: 80.257 Change: 1.4 % Gilead Sciences, Inc. Stock Price Forecast for 2027 April 2027 Open: 85.360 Close: 84.903 Min: 86.208 Max: 88.414 Change: -0.54% Change: 3.09 % Change: 1.97% Change : 1.02% Change.

Stock Profile

"Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California."

Keywords

The game is changing. There is a new strategy to evaluate Gilead Sciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Gilead, Sciences, Change, stock, USD, Current, liver, and the most common words in the summary are: gilead, science, stock, price, forecast, inc, market, . One of the sentences in the summary was: Gilead Sciences stock quote is 81.59 USD today. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #gilead #science #stock #price #forecast #inc #market.